LYTIR

Insider · SEC Form 4 · Director

Charles Cliff Duncan

Filed with the SEC as Duncan Charles Cliff; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $38K of VNDA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. VNDABought: Vanda Pharmaceuticals Inc. Nov 5, 2026 5,803 shares filed Nov 5, 2026 108,701 shares held directly after, as filed filing $22K
  2. VNDABought: Vanda Pharmaceuticals Inc. Nov 4, 2026 3,447 shares filed Nov 5, 2026 102,898 shares held directly after, as filed filing $13K
  3. VNDABought: Vanda Pharmaceuticals Inc. Nov 3, 2026 750 shares filed Nov 5, 2026 99,451 shares held directly after, as filed filing $3K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.